Kelly Allott

Kelly Allott

Auto-generated profile, based on publicly available information

Kelly Allott

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in World Psychiatry
Verified
Journal Article
Open access
PDF file
PMPatrick McGorry
Patrick McGorry
MKMatcheri Keshavan
Matcheri Keshavan
SGSherilyn Goldstone
Sherilyn Goldstone
PAPaul Amminger
Paul Amminger
KAKelly Allott
Kelly Allott
IHIan Hickie
Ian Hickie
Personalized medicine is rapidly becoming a reality in today's physical medicine. However, as yet this is largely an aspirational goal in psychiatry, despite significant advances in our understanding of the biochemical, genetic and neurobiological processes underlying major mental disorders. Preventive medicine relies on the availability of predictive tools; in psychiatry we still largely lack these. Furthermore, our current diagnostic systems, with their focus on well-established, largely chronic illness, do not support a pre-emptive, let alone a preventive, approach, since it is during the early stages of a disorder that interventions have the potential to offer the greatest benefit. Here, we present a clinical staging model for severe mental disorders and discuss examples of biological markers that have already undergone some systematic evaluation and that could be integrated into such a framework. The advantage of this model is that it explicitly considers the evolution of psychopathology during the development of a mental illness and emphasizes that progression of illness is by no means inevitable, but can be altered by providing appropriate interventions that target individual modifiable risk and protective factors. The specific goals of therapeutic intervention are therefore broadened to include the prevention of illness onset or progression, and to minimize the risk of harm associated with more complex treatment regimens. The staging model also facilitates the integration of new data on the biological, social and environmental factors that influence mental illness into our clinical and diagnostic infrastructure, which will provide a major step forward in the development of a truly pre-emptive psychiatry.

1 December 2004 in Journal of Personality Disorders
Verified
Journal Article
Closed access
ACAndrew M. Chanen
Andrew M. Chanen
HJHenry J. Jackson
Henry J. Jackson
PMPatrick D. McGorry
Patrick D. McGorry
KAKelly A. Allot
Kelly A. Allot
VCVerity Clarkson
Verity Clarkson
HYHok Pan Yuen
Hok Pan Yuen

1 February 2011 in Schizophrenia Research
Verified
Journal Article
Closed access
KAKelly Allott
Kelly Allott
PLPing Liu
Ping Liu
TPTina-Marie Proffitt
Tina-Marie Proffitt
EKEoin Killackey
Eoin Killackey

16 November 2007 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
HJH. J. Jackson
H. J. Jackson
PMP. D. McGorry
P. D. McGorry
EKE. Killackey
E. Killackey
SBS. Bendall
S. Bendall
KAK. Allott
K. Allott
SHS. Harrigan
S. Harrigan
Background: The ACE project involved 62 participants with a first episode of psychosis randomly assigned to either a cognitive behaviour therapy (CBT) intervention known as Active Cognitive Therapy for Early Psychosis (ACE) or a control condition known as Befriending. The study hypotheses were that: (1) treating participants with ACE in the acute phase would lead to faster reductions in positive and negative symptoms and more rapid improvement in functioning than Befriending; (2) these improvements in symptoms and functioning would be sustained at a 1-year follow-up; and (3) ACE would lead to fewer hospitalizations than Befriending as assessed at the 1-year follow-up.Method: Two therapists treated the participants across both conditions. Participants could not receive any more than 20 sessions within 14 weeks. Participants were assessed by independent raters on four primary outcome measures of symptoms and functioning: at pretreatment, the middle of treatment, the end of treatment and at 1-year follow-up. An independent pair of raters assessed treatment integrity.Results: Both groups improved significantly over time. ACE significantly outperformed Befriending by improving functioning at mid-treatment, but it did not improve positive or negative symptoms. Past the mid-treatment assessment, Befriending caught up with the ACE group and there were no significant differences in any outcome measure and in hospital admissions at follow-up.Conclusions: There is some preliminary evidence that ACE promotes better early recovery in functioning and this finding needs to be replicated in other independent research centres with larger samples.

22 April 2018 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
JGJoanne Goodall
Joanne Goodall
CFCaroline Fisher
Caroline Fisher
SHSarah Hetrick
Sarah Hetrick
LPLisa Phillips
Lisa Phillips
EPEmma M. Parrish
Emma M. Parrish
KAKelly Allott
Kelly Allott

1 November 2012 in Schizophrenia Research
Verified
Journal Article
Closed access
ATAndrew Thompson
Andrew Thompson
APAlicia Papas
Alicia Papas
CBCali Bartholomeusz
Cali Bartholomeusz
KAKelly Allott
Kelly Allott
GAG. Paul Amminger
G. Paul Amminger
AYAlison Yung
Alison Yung